Last month was definitely a busy one for us and to top it off, Jupiter Orphan Therapeutics (JOT) announced their collaboration with InSymbiosis (http://www.prnewswire.com/news-releases/jupiter-orphan-therapeutics-inc-partners-with-insymbiosis-300445069.html).
This collaboration will help JOT in managing its clinical trial manufacturing and supply as well as execution of it human pharmacokinetic/pharmacodynamics (PK/PD) studies. With such collaboration, InSymbiosis will allow JOT to remain virtual and help advance their programs more efficiently and effectively towards key value inflection points.
To learn more about JOT, please visit their website! http://www.jupiterorphan.com/
The InSymbiosis Team